Carl Zeiss Meditec AG
AFX: XETR (DEU)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
€27.00 | Ktypbf | Xwmpdyxl |
Carl Zeiss Sustains Strong Growth and Margin in Q2 Despite Headwinds; Maintain EUR 69 FVE
Narrow-moat Carl Zeiss Meditec reported about as-expected fiscal second-quarter results with 10.7% currency-adjusted sales growth and roughly flat year-over-year adjusted operating margin. We maintain our EUR 69 fair value estimate; shares remain overvalued.